1. Home
  2. TLSA vs KNDI Comparison

TLSA vs KNDI Comparison

Compare TLSA & KNDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tiziana Life Sciences Ltd.

TLSA

Tiziana Life Sciences Ltd.

HOLD

Current Price

$1.29

Market Cap

155.2M

Sector

Health Care

ML Signal

HOLD

KNDI

Kandi Technologies Group Inc

HOLD

Current Price

$1.01

Market Cap

67.8M

ML Signal

HOLD

Company Overview

Basic Information
Metric
TLSA
KNDI
Founded
2013
2002
Country
United Kingdom
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Auto Manufacturing
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
155.2M
67.8M
IPO Year
2017
2021

Fundamental Metrics

Financial Performance
Metric
TLSA
KNDI
Price
$1.29
$1.01
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
108.9K
155.6K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.73
$0.78
52 Week High
$2.60
$1.77

Technical Indicators

Market Signals
Indicator
TLSA
KNDI
Relative Strength Index (RSI) 41.88 59.08
Support Level N/A $1.02
Resistance Level $1.61 $1.11
Average True Range (ATR) 0.11 0.06
MACD -0.01 0.00
Stochastic Oscillator 20.27 99.15

Price Performance

Historical Comparison
TLSA
KNDI

About TLSA Tiziana Life Sciences Ltd.

Tiziana Life Sciences Ltd is a clinical stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. The company's clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, Alzheimer's, and ALS. Its flagship immunotherapeutic candidate, Foralumab (TZLS-401), which is a fully human anti-CD3 monoclonal antibody, is being developed for Non-Active Secondary Progressive Multiple Sclerosis, Alzheimer's and other CNS indications.

About KNDI Kandi Technologies Group Inc

Kandi Technologies Group Inc is engaged in developing, manufacturing, and commercializing fully electric vehicle products and related technologies. Its products mainly consist of EV parts, EV products, and off-road vehicles, including All-Terrain Vehicles (ATVs), UTVs, go-karts, electric scooters, electric self-balancing scooters, and associated parts, and Lithium-ion cells, etc. The company generates maximum revenue from the sale of Off-road vehicles and associated parts. Geographically, it derives maximum revenue from the United States and other countries, followed by China.

Share on Social Networks: